The kinetics of the reactions of glutathione (GSH) with 4-hydroperoxycyclophosphamide (4OOH-CP) and acrolein, a metabolite of 4OOH-CP, were investigated in a cell-free medium (pH ϳ7.5) and peripheral blood mononuclear cells. The ability of the thiol drugs, sodium 2-mercaptoethane sulfonate (mesna) and S-2-(3-aminopropylamino)ethanethiol (WR-1065), to affect the reactions of cellular GSH with the alkyalting agents was also studied. The amount of unreacted thiols in the various reactions was determined by derivatization with monobromobimane, followed by separation of fluorescent-labeled thioether adducts using high-pressure liquid chromatography. The second-order rate constants (k 2 ) for reactions of GSH, mesna, and WR-1065 with 4OOH-CP in solution were 38 ؎ 5, 25 ؎ 5, and 880 ؎ 50 M , respectively. The apparent rate constants for reactions of cellular GSH with acrolein and 4OOH-CP were smaller than those obtained in solution. Assuming that the k 2 is the same inside and outside cells, we estimate the first-order rate constant (k 1 ) for transfer of 4OOH-CP and acrolein across the cell membrane as ϳ0.01 and ϳ0.04 s ؊1 , respectively. WR-1065 was more effective than mesna in blocking depletion of cellular GSH (because it passes into the cell more quickly and has higher reaction rates with the alkylators than the latter compound). When WR-1065 and mesna were used together, the protection against cellular depletion of GSH was additive. Our results are relevant to the administration of thiol drugs with highdose alkylating agents.
Cyclophosphamide [cis-(Ϯ)-2-(bis(2-chloroethyl)amino)tetrahydro-2-oxide-2H-1,3,2-oxazaphosphorine] is a leading anticancer agent. Activation of the drug requires hydroxylation by the hepatic microsomal cytochrome P-450 system in vivo. The resulting 4-hydroxylated metabolite spontaneously degrades via ␤-cleavage of its aldophosphamide tautomer to phosphoramide mustard (an active anticancer component) and acrolein (a highly electrophilic, ␣,␤-unsaturated aldehyde) (Hohorst et al., 1976; Colvin, 1999; Kehrer and Biswal, 2000) . Moreover, aldophosphamide is oxidized by aldehyde dehydrogenase to the inactive metabolite carboxyphosphamide (Bunting and Townsend, 1998; Sladek, 1999; Giorgianni et al., 2000) . Other minor oxidations include dechloroethylation of a chloroethyl side chain to dechloroethylated metabolite and chloroacetaldehyde (Ludeman, 1999) .
The reaction mechanism of phosphoramide mustard [N,N-bis-2-(2-chloroethyl)phosphorodiamidic acid, R-N(CH 2 -CH 2 -Cl) 2 ] involves generation of the intermediate phosphoramide aziridinium ion through an intramolecular nucleophilic attack (cyclization reaction) of the nitrogen on the ␤-carbon of a chloroethyl chain (Ludeman, 1999) .
Cellular thiols (e.g., GSH 1 ) and other nucleophiles react rapidly with phosphoramide aziridinium ions, producing thioether products (Gamcsik et al., 1999) . Moreover, reversible 4-(alkylthio)cyclophosphamide products have been observed (Hohorst et al., 1976; Niemeyer et al., 1984; Kwon et al., 1987; Lee, 1991a,b) .
Reactions of thiols with acrolein (CH 2 ϭ CH-CHO), on the other hand, are via nucleophilic addition at the ␤Ϫcarbon atom, forming stable thioether compounds (e.g., 3-oxopropyl glutathione) (Ramu et al., 1995 (Ramu et al., , 1996 .
The 4-hydroxycyclophosphamide, aldophosphamide, and acrolein metabolites can readily cross the cell membrane. In contrast, phosphoramide mustard bears a negative charge at physiologic pH (pK a ϳ4.8) and, thus, is relatively membrane impermeable. Phosphoramide mustard is, therefore, primarily generated intracellularly (Boyd et al., 1986) .
In vitro systems have employed 4OOH-CP as an activated congener of cyclophosphamide, which spontaneously degrades to the reactive alkylating metabolites (Blomgren and Hallstrom, 1991) . The 4OOH-CP compound is used clinically to purge hematopoietic cells prior to autologous bone marrow transplantation.
The sulfhydryl compounds, mesna (HS-CH 2 -CH 2 SO 3 Na), and WR-2721 [amifostine, S-2-(3-aminopropylamino) ethyl phosphorothioic acid, ϩ H 3 N-(CH 2 ) 3 -NH 2 ϩ -(CH 2 ) 2 -S-PO 3 H Ϫ ] are commonly used to ameliorate toxicities of cyclophosphamide and platinum-based compounds (Brock et al., 1982; Souid et al., 1999; Sadowitz et al., 2002) . The protective mechanism of mesna and WR-1065 [WR-2721 active metabolite, ϩ H 3 N-(CH 2 ) 3 -NH 2 ϩ -(CH 2 ) 2 -SH] involves the thiolate anions that participate in chemical reactions similar to those of GSH (Danehy and Noel, 1960) . However, the reaction of mesna with the chloroethyl moieties of phosphoramide mustard is unfavorable (Seitz et al., 1989) .
The distribution of WR-1065 and mesna differs markedly. WR-1065 distributes equally between the extra-and intracellular compartments, whereas mesna distributes mostly in the extracellular compartment (Newton et al., 1996; Souid et al., 2001) .
The aim of the present study is to investigate the kinetics of reactions that are important for optimizing the clinical use of WR-1065 and mesna with high-dose alkylating agents. We estimated the rate constants for reactions of the protective thiols and GSH with 4OOH-CP and acrolein in a cell-free medium at physiologic pH (ϳ7.5). We also investigated the kinetics of depletion of GSH inside PBMC by 4OOH-CP and acrolein in the presence and absence of mesna and WR-1065. The protective capacity of WR-1065 is compared with that of mesna, to provide a framework for drug thiol use during administration of high-dose alkylating agents.
Materials and Methods
Chemicals. 4OOH-CP (D-18864, MW 293.1) was obtained from ASTA Medica AG (Frankfurt, Germany); mesna (MW 164.18, purchased as 100 mg/ml solution) was obtained from Bristol-Myers Squibb Co. (Princeton, NJ); WR-1065 ⅐ 2HCl (MW 207.16) was obtained from US Bioscience (West Conshohocken, PA); Ficoll-Paque from Amersham Biosciences AB (Uppsala, Sweden); methanesulfonic acid (MSA) and tris(hydroxymethyl)-aminomethane (Tris) was purchased from Fluka BioChemika (Ronkonkoma, NY); mBBr was purchased from Molecular Probes Inc. (Eugene, OR); acrolein (90%, or ϳ15 M solution), GSH, 5,5Ј-dithio-bis(2-nitrobenzoic acid) (DTNB) and anhydrous Na 2 HPO 4 were obtained from Sigma-Aldrich (St. Louis, MO); and RPMI 1640 medium (pH 7.15, without L-glutamine) were purchased from Mediatech (Herndon, VA).
The study was approved by the institutional review board (State University of New York, Upstate Medical University) for the protection of human subjects.
Solutions. Mesna and WR-1065 solutions were prepared in dH 2 O and stored at Ϫ70°C in small aliquots; their concentrations were determined by titration with DTNB immediately prior to each use (Souid et al., 1998) . Solutions of 4OOH-CP and acrolein were made in dH 2 O immediately prior to their use in various experimental procedures and kept on ice. The mBBr (0.1 M in acetonitrile) and 2 M thiol-bimane standard solutions were prepared and stored as described (Souid et al., 1998) .
Reactions of GSH, Mesna, and WR-1065 with 4OOH-CP and Acrolein. Reactions were carried out at 22 Ϯ 2°C in flat-bottom glass vials with rapid stirring via a magnetic stirring bar in a total volume of 200 l containing 20 mM Na 2 HPO 4 and the thiol (final pH, ϳ7.5). Reactions were started by adding the alkylating agent (4OOH-CP or acrolein). At times indicated in the figures, reactions with thiol were terminated by adding 0.8 ml of 5 mM (final concentration) mBBr (diluted in 10 mM Na 2 HPO 4 immediately prior to each addition), which reacts with the thiolate anion to form a fluorescent thioether derivative. Dilution of the medium by the addition of mBBr reduces the rate of reaction of thiol with alkylating agent by ϳ5-fold. The samples were then incubated in the dark at room temperature (RT) for 15 min. Twenty microliters of 5 M MSA were added, mixed, and extracted with 1.0 ml H 2 Osaturated CH 2 Cl 2 . Portions of the aqueous layers were loaded on high-pressure liquid chromatography (HPLC) and analyzed as described (Souid et al., 1999) .
A linear calibration curve, from 0 to 100 pmol of mixed thiol standard was generated with each analytical run (r Ͼ 0.99). Peak identification was confirmed by retention time in comparison with authentic standards. Quantification was based on peak area against the appropriate reference standards.
Reaction of the thiolate ions with the alkylating metabolites are as shown in eq. 1:
where RSH ϭ GSH, mesna or WR-1065 and A ϭ 4OOH-CP or acrolein. Equation 1 is the ionization of the thiol, characterized by its pK a . If the kinetics to reach equilibrium for eq. 1 are rapid, the concentration of RS Ϫ is proportional to the concentration of RSH, and the equilibrium can be ignored. The alkylation reaction then becomes
These chemical reactions are illustrated in Schemes 1 and 2. Reaction (eq. 2), with the effective rate constant k 2 , is thus a mixed secondorder reaction, and the rate equation is easily integrated. The reaction of a thiolate ion with mBBr to form the bimane (thioether) adduct RS-B (Scheme 3) is also a mixed second-order reaction with the rate constant k 2Ј , The kinetics of alkylation reactions were analyzed using the second-order rate equation:
In eq. 
The pseudo-first-order rate equation (eq. 6) was used when the concentration of alkylator was in large (Ͼ25-fold) excess, so [A] always remained close
The pseudo-first-order rate constant (k 1 , s
Ϫ1
) in this case is
The t 1/2 (s) for depletion of thiol for pseudo-first-order reactions is calculated as
The stability of acrolein in Na 2 HPO 4 at RT was determined using HPLC (Beckman Coulter Inc., Fullerton, CA) as follows. Acrolein was detected at 310 nm using a spectrophotometer equipped with a standard flow cell. The column, 4.6 ϫ 250 mm Beckman Ultrasphere IP (Beckman Coulter Inc.) was operated at RT at 1.0 ml/min. Separation was carried out using a two solvent system. Solvent A was 0.1% (v/v) trifluoroacetic acid-water and solvent B HPLC-grade methanol. The chromatography employed one-step linear gradients of 5 to 50% solvent B over 10 min. Acrolein peak was detected at ϳ9 min. The t 1/2 for acrolein decay in 20 mM Na 2 HPO 4 (pH, ϳ7.5) was Ͼ4 h. PBMC Collection. Blood was freshly drawn from healthy volunteers into heparin containing Vacutainer tubes (BD Biosciences, San Jose, CA). PBMC were collected and counted as described (Souid et al., 2001) .
Incubation of PBMC with Drugs. In all experiments, ϳ10 7 cells per condition were incubated in RPMI medium in a final volume of 1.0 ml at 37°C for 60 min. A control sample with no addition was incubated along with the experimental conditions. Mixing was by rapid inversions. Cells were preincubated with WR-1065 or mesna for 5 min before adding 4OOH-CP or acrolein. At the end of the incubation period, the cells were collected by centrifugation, suspended in 20 mM Tris-MSA (pH 8.0) and 5 mM mBBr (final volume 0.5 ml), and incubated in the dark at RT for 15 min. The amount of GSH in the cellular acid-soluble supernatants was determined using HPLC as described (Souid et al., 1998) . Most experiments were carried out in triplicates. Calculations were based on the amount of GSH per reaction volume and dry cellular pellet weight; both methods gave the same results. Similar results were obtained at pH 7.7.
The amount of WR-1065 labeled by mBBr is the same in cells and plasma (Souid et al., 1999 (Souid et al., , 2001 ). Thus, the labeling efficiency in both environments appears to be the same. In any event, only the relative change in concentration was used to find the kinetic parameters in the cell.
Results

Kinetics of Thiol Reactions with 4OOH-CP and Acrolein in a
Cell-Free Solution. We first explored the rates of reactions of mBBr (500 M) with GSH, mesna, and WR-1065 (100 M) in 20 mM Na 2 HPO 4 , pH 7.5 (final volume, 200 l). The mixtures were incubated at RT for 15 to 120 s and quenched by lowering the pH with 5 l of 5 M MSA. The results are given in Fig. 1 , where the quantity
(see eq. 3) is plotted. The value of k 2Ј for the reaction of GSH with mBBr was 7.
.0 min), and WR-1065 9.4 Ϯ 0.9 M Ϫ1 s Ϫ1 (t 1/2 , 2.6 min), Fig. 1 (r Ͼ 0.98 for all three).
We then explored the rates of reactions of 4OOH-CP and acrolein with the thiols, using 5 mM mBBr to quench the reactions. With this large excess of mBBr, the labeling reaction is pseudo-first-order, with k 1 between 0.03 and 0.05 s Ϫ1 and t 1/2 between 15 and 23 s (calculated using eqs. 7 and 8, respectively).
Unfortunately, the k 2 values for the reactions of thiols with acrolein and 4OOH-CP (Table 1) are much larger than the k 2Ј values given above. Thus, even though the mBBr concentration is much larger than those of acrolein and 4OOH-CP, the thiol-alkylation reaction competes with the thiol-labeling reaction, and not all of the thiol is derivatized with mBBr. One should really consider simultaneous second-order equations:
Reaction of a thiol with phosphoramide mustard.
SCHEME 3. Reaction of a thiol with mBBr to form the bimane (thioether) adduct RS-B.
FIG. 1. Kinetics of thiol reactions with mBBr.
The reactions contained 20 mM Na 2 HPO 4 (pH 7.5), either 100 M GSH, 100 M mesna or 100 M WR-1065, and 500 M mBBr (final volume 200 l). The mixtures were incubated at RT for indicated time. At the end of the incubation periods, 5 l of 5 M MSA were added. The samples were then diluted to 1.0 ml with 10 mM MSA and extracted with 1.0 ml H 2 O-saturated CH 2 Cl 2 . The thiol-bimane derivatives were quantitated on HPLC as described under Materials and Methods. Spontaneous oxidation of the thiols during the 120-s period was Ͻ1%. Shown are values of ln Q (see eq. 3) calculated from experimental data for GSH (circles), mesna (squares), and WR-1065 (diamonds). Linear least-square fits to ln Q versus t are shown (solid, long-dashed, and short-dashed lines, respectively); k 2 is determined from the slope in each case.
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at ASPET Journals on September 6, 2017 dmd.aspetjournals.org The GSH reaction with 4OOH-CP (Fig. 2 , circles) contained 100 M GSH and 50 M 4OOH-CP. Data were taken to t ϭ 900 s (not shown), but only results to t ϭ 300 s (14 points) were used to obtain k 2 , giving 25 Ϯ 5 M Ϫ1 s Ϫ1 (r ϭ 0.87) and t 1/2 320 Ϯ 60 s. The best-fit line is far from going through the origin; if we impose a zero y-intercept, the best-fit line (r ϭ 0.57) gives k ϭ 38 Ϯ 5 M Ϫ1 s Ϫ1 . The mesna reaction with 4-OOH-CP (Fig. 2, squares ) contained 200 M mesna and 100 M 4OOH-CP. Eight data points were taken to t ϭ 120 s; k 2 was calculated as 25 Ϯ 5 M Ϫ1 s Ϫ1 (r ϭ 0.91), giving t 1/2 ϭ 164 Ϯ 31 s. The WR-1065 reaction with 4-OOH-CP (Fig. 2, triangles) contained 100 M WR-1065 and 75 M 4OOH-CP. Ten data points were taken to t ϭ 60 s; k 2 was calculated as 880 Ϯ 50 M Ϫ1 s Ϫ1 (r ϭ 0.98), giving t 1/2 ϭ 10.2 Ϯ 0.6 s.
The GSH reaction with acrolein ( Fig. 3 , circles) contained 100 M GSH and 50 M acrolein; k 2 was 490 Ϯ 100 M Ϫ1 s Ϫ1 , and t 1/2 was 16 Ϯ 3 s. The mesna reaction with acrolein (Fig. 3 , squares) contained 200 M mesna and 100 M acrolein; k 2 was 700 Ϯ 150 M Ϫ1 s Ϫ1 , and t 1/2 was 5.6 Ϯ 1.2 s. The WR-1065 reaction with acrolein was too fast for accurate measurement of k 2 . From the data, it appears that it is greater than 2000 M Ϫ1 s Ϫ1 . Rates of the Reversed Chemical Reactions. The rate for removal of thiolates from products formed in the reaction of alkylating agents with thiols (that is, the reverse rate) was investigated by adding 5 mM mBBr to reactions containing 100 to 200 M thiol (GSH, mesna, or WR-1065) and 50 to 100 M alkylating agent (acrolein or 4OOH-CP). The mixtures were incubated for 1, 5, or 15 min before the The reactions were performed at 22 Ϯ 2°C in 20 mM Na 2 HPO 4 , pH 7.5 (final volume 200 l). The GSH reactions contained 100 M GSH and 50 M 4OOH-CP, the mesna reactions 200 M mesna and 100 M 4OOH-CP, and the WR-1065 reactions 100 M WR-1065 and 75 M 4OOH-CP. At the end of the incubation periods, 0.8 ml of mBBr was added (final mBBr concentration 5 mM), and the samples were incubated in the dark at RT for 5 min. Five l of 5 M MSA were then added, and the samples were diluted to 1.0 ml with 10 mM MSA and extracted with 1.0 ml H 2 O-saturated CH 2 Cl 2 . The supernatants were analyzed on HPLC as described under Materials and Methods. Ln Q (eq. 3) is calculated from the results for GSH (circles), mesna (squares), and WR-1065 (triangles) and fitted to lines (solid, short-dashed, and long-dashed, respectively). The k 2 values are derived from the slopes of the lines.
FIG. 3. Kinetics of thiol reactions with acrolein.
The reactions were performed at 22 Ϯ 2°C in 20 mM Na 2 HPO 4 , pH 7.5 (final volume 200 l). The GSH reactions contained 100 M GSH and 50 M acrolein, the mesna reactions 200 M mesna and 100 M acrolein, and the WR-1065 reactions 100 M WR-1065 and 50 M acrolein. At the end of the incubation periods, 0.8 ml mBBr was added (final mBBr concentration 5 mM), and the samples were incubated in the dark at RT for 5 min. Five l of 5 M MSA were then added, and the samples were diluted to 1.0 ml with 10 mM MSA and extracted with 1.0 ml H 2 O-saturated CH 2 Cl 2 . The supernatants were analyzed on HPLC as described under Materials and Methods. Values of ln Q (eq. 3) calculated from measurements are plotted (circles for GSH, squares for mesna) and fitted to lines (solid and dashed, respectively) to obtain k 2 values. For WR-1065, k 2 was too large for measurement (data not shown). Fitting the results in the left panel to an exponential (dashed curve), we find that 50% cellular GSH depletion occurs for 39 M 4OOH-CP, 90% for 123 M, and 95% for 159 M. Acrolein was more effective than 4OOH-CP at depleting cellular GSH. Fitting the results in the right panel to an exponential (dashed curve) shows that, with acrolein, 50% cellular GSH depletion occurs for 6 M acrolein, 90% for 20 M, and 95% for 25 M. Exponential fits are appropriate if the rate of transfer of alkylating agent across the cell membrane is much faster than the rate of reaction.
Kinetics of Cellular GSH Depletion by 4OOH-CP and Acrolein. Figure 5 , filled circles, shows PBMC GSH depletion as a function of time with 100 M 4OOH-CP (left panel) or 20 M acrolein (right panel) in the incubation medium. If the rate of transfer of alkylating agent across the cell membrane is much faster than the rate of reaction inside the cell, the kinetics becomes pseudo-first-order, and fitting the data to exponentials (dashed curves) is justified. This gives, for 4OOH-CP, a pseudo-first-order rate constant (k 1 ) of 0.099 Ϯ 0.009 min Ϫ1 and t 1/2 ϭ 7.0 Ϯ 0.6 min (r ϭ 0.98). Since [4OOH-CP] ϭ 100 M, the k 2 for reaction of 4OOH-CP with cellular GSH is 16.5 M Ϫ1 s Ϫ1 (calculated using eq. 7). This is lower than the k 2 for reaction of 4OOH-CP with extracellular GSH, 38 M Ϫ1 s Ϫ1 (Table 1) . Acrolein depletes cellular GSH much more quickly than 4OOH-CP; fitting the data for acrolein to exponential decay gives 0.26 Ϯ 0.10 min Ϫ1 for the k 1 and t 1/2 ϭ 2.7 Ϯ 1.0 min (r ϭ 0.79). Table 1 ) may be that the transport of the alkylating agents across the cell membrane is not extremely fast, or that k 2 is slower inside the cell than in the cell-free medium. However, since the reactants are small molecules that collide by diffusion through solvent, the overall rates leading to product inside and outside the cell should be comparable. If one assumes that k 2 is the same inside and outside the cell, one can estimate the transport rate coefficient. Nevertheless, since the experimental conditions are not identical, these coefficient values should be considered approximates.
Let [A] be the concentration of alkylating agent in the intracellular space and A e the concentration in the extracellular medium. Assume that A e is held constant in time and that the rate of transport into the intracellular space is proportional to A e Ϫ [A]. Then 
which integrates to
FIG. 4. Cellular GSH depletion by 4OOH-CP and acrolein.
PBMC (ϳ10 7 cells per condition) were incubated with 0 to 150 M 4OOH-CP or 0 to 20 M acrolein at 37°C for 60 min. The cells were then collected by centrifugation, suspended in 20 mM Tris-MSA containing 5 mM mBBr, and incubated at RT for 15 min. The amount of GSH in the cellular acid-soluble supernatants was determined on HPLC. The GSH content in the control sample (cells incubated with no addition) was set as 100%. Concentration of alkylating agent is plotted versus measured fraction GSH recovered. The quantity [S]/[S] 0 , is the fraction of GSH remaining. Dashed curves are best exponential fits, assuming infinitely fast transfer across cell membrane. Solid curves are fits to complete model, assuming k 2 equal to its value for homogeneous solution and finding best value for transfer rate constant.
FIG. 5. Kinetics of cellular GSH depletion by 4OOH-CP (left panel) and acrolein (right panel).
PBMC (ϳ10 7 cells per condition) were incubated with 100 M 4OOH-CP or 20 M acrolein at 37°C for various times. At the end of the incubation periods, the reactions were quenched by adding 5 mM mBBr. The cells were then collected by centrifugation, re-suspended in 20 mM Tris-MSA and 5 mM mBBr, and incubated at RT for 15 min. The amount of GSH in the cellular acid-soluble supernatants was determined on HPLC. The GSH content in the control sample (cells incubated at 37°C with no addition) was set as 100%. Filled circles are experimental results. Dashed curves are best exponential fits (assuming very fast transfer of alkylating agents across cell membrane). Solid curves are fits to complete model, assuming k 2 equals the value for bulk solution and choosing transfer rate constant to obtain the best fit to the data. The quantity [S]/[S] 0 is the fraction of GSH remaining.
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Since A e and t appear in eq. 10 only as product, we use eq. 10 to fit the data for cellular GSH depletion as a function of A e (t fixed) and the data for cellular GSH depletion as a function of t (A e fixed). We set k 2 for each alkylating agent equal to the value determined for cell-free solution and find k 1 by minimizing the sum, for all [S] , of the squared deviations of experimental A e values from calculated A e . We assume [S] 0 ϭ 2 mM, an approximate concentration of cellular GSH. The precision of the data does not justify varying all three parameters (k 1 , k 2 , and [S] 0 ) to obtain the best fits to eq. 10.
Treating the concentration-dependent data for 4OOH-CP and acrolein (Fig. 4) in this way gives k 1 ϭ 0.006 s Ϫ1 for 4OOH-CP and 0.037 s Ϫ1 for acrolein. The resulting plots are shown as solid curves in Fig.  4 . The sum of the squared deviations of A e (fitted) from A e (measured) is 9 ϫ 10 Ϫ10 M 2 for 4OOH-CP and 2.1 ϫ 10 Ϫ11 M 2 for acrolein. The dashed curves are the fits to ln {[S]/[S] 0 } ϭ Ϫk 2 A e t, with the best value of k 2 . The sum of the squared deviations of A e (fitted) from A e (measured) is 6 ϫ 10 Ϫ10 M 2 for 4OOH-CP and 6 ϫ 10 Ϫ11 M 2 for acrolein. The model of eq. 10 is clearly superior for acrolein, and both models are equally good for 4OOH-CP.
The time-dependent data of Fig. 5 is treated the same way. Assuming [S] o ϭ 2 mM and k 2 ϭ cell-free solution value, we find the value of k 1 that minimizes the sum of the squared deviations of t (fitted) from t (measured). The results are shown in Fig. 5 as solid curves, the sum of the squared deviations being 60 min 2 for 4OOH-CP, for which k 1 ϭ 0.018 s Ϫ1 . The best fits to the logarithmic functions are shown as dashed curves. For 4OOH-CP, the sum of the squared deviations is 157 min 2 , so the model of eq. 10 is clearly superior. For acrolein (right panel of Fig. 5 ), both models are equally good. The best logarithmic fit gives k 2 ϭ 427 s Ϫ1 (sum of squared deviations ϭ 13.6) and the best fit to (10) gives k 1 ϭ 4.0 s Ϫ1 (sum of squared deviations ϭ 14.2). The data point for t ϭ 1 min is clearly wrong, since ([S]/[S] o must be significantly larger for 1 min than for 2 min. Although this point makes both fits look poor, it was left in and used in the fits because there was no specific reason to eliminate it.
Cellular GSH Protection by Mesna and WR-1065. Figure 6 , left panel, shows PBMC GSH protection by mesna (squares) and WR-1065 (circles) in the presence of 100 M 4OOH-CP. Figure 6 , right panel, shows PBMC GSH protection by mesna (squares) and WR-1065 (circles) in the presence of 20 M acrolein. The protection (P) is calculated according to P ϭ 100 ϫ GSH recovered from cells after exposure to alkylator GSH recovered from cells not exposed to alkylator
Measurement of the quantity in the denominator was performed four times, giving 378, 347, 450, and 387 pmol per 50 l (volume injected into HPLC), i.e., 390 Ϯ 37.5 (mean and root mean square deviation from the mean). If the same 9.6% uncertainty obtains for all measurements of GSH recovered, the uncertainty in each value of P is 13.6%.
Modeling the results of these experiments would require taking into account the following processes: 1) extracellular reaction of alkylating agent with drug thiol; 2) transport of the alkylating agent and the drug thiol across the cell membrane; 3) reaction of the alkylating agent with the drug thiol in the intracellular medium; and 4) intracellular reaction of the alkylating agent with GSH. In addition to a rate constant associated with each of these processes, a value for intracellular GSH would have to be assumed. It does not seem advisable to try to fit the experimental results by adjusting so many parameters, although values for some of these are obtainable from the experiments discussed previously. We have performed numerical calculations, integrating all the rate equations. The results show that a plot of P versus drug thiol concentration [D] should be S-shaped.
For the four sets of data in Fig. 6 , we have fit P-P 0 , where P 0 is the protection with no drug thiol, as a function of c, concentration of drug thiol, to the S-shaped two-parameter function
Here P 0 is the measured protection, as defined by eq. 11, for a drug thiol concentration of zero, and B and C are fitting parameters. The quantity, P 0 , would be zero if the incubation time were infinite. The resulting plots are shown in Fig. 6 , solid for WR-1065 and dashed for mesna. Agreement between the fitting function and experiment is within the stated 13.6% of experimental error. The fit for mesna and 4OOH-CP is not shown, because it is largely determined by a single point (P ϭ 30%, [D] ϭ 1 mM). Clearly, WR-1065 gives greater protection than mesna against both 100 M 4OOH-CP and 20 M acrolein. For 4OOH-CP, P increased only slightly for WR-1065 concentrations less than 400 M, but complete protection (P ϭ 100) was observed at concentrations Ն800 M (Fig. 6, left panel, circles) . In contrast, P never exceeded 32% for mesna. Table 2 shows the results of protection experiments using 50 M extracellular mesna, 50 M extracellular WR-1065, and both. The alkylating agent was acrolein, also extracellular. It is clear that the combination of drug thiols gives more cytoprotection than either separately. The PBMC GSH level is reduced to 3% by the presence of Cellular GSH Protection by Intracellular Mesna and WR-1065. The contribution of intracellular drug thiols to cellular GSH protection was also investigated. PBMC (ϳ10 7 cells per condition) were first incubated (37°C for 30 min) in RPMI medium without or with 300 M mesna or WR-1065. Cells were then collected by centrifugation, suspended in fresh medium without or with 20 M acrolein, and re-incubated at 37°C for 60 min. At the end of the incubation period, cells were collected, labeled with mBBr, and analyzed for glutathionebimane-bimane derivatives as described under Materials and Methods. The percentage of GSH was calculated as 100 times the ratio of amount of GSH found to amount of GSH in the control sample (that is, cells incubated without any addition). The percentage of GSH in the absence of drug thiols was ϳ6%, whereas the presence of either mesna or WR-1065 raised this to ϳ40%. Although the k 2 values for WR-1065 and mesna with acrolein are different (Table 1) , the long period of the reaction, 60 min, insures that all of the acrolein has been consumed in the alkylation process.
Discussion
Rate constants were measured for reactions of thiols (GSH, mesna, and WR-1065) with mBBr ( Fig. 1) . It was concluded that with 5 mM mBBr, the rate of thiol reaction with mBBr is faster than the rate of thiol reaction with 4OOH-CP and acrolein (at the concentrations used in most of our experiments). This means that mBBr at this concentration can be used to quench most thiol reactions with 4OOH-CP and acrolein. If the reaction with mBBr is not fast enough, the term "ln Q" in eq. 3 will not be a linear function of time, as it should be for second-order reactions. Numerical calculations (shown under Results) explained how to treat experimental data when this is the case.
We then examined reactions of GSH, mesna, and WR-1065 with 4OOH-CP and acrolein in Na 2 HPO 4 buffer at physiologic pH (ϳ7.5) and 22 Ϯ 2°C (Fig. 2-3) . The rate constants obtained from these measurements are given in Table 1 . These values are "effective rate constants" since they are calculated using total thiol concentration, whereas thiols react mainly by nucleophilic attack of thiolate anions on the reactive moieties of 4OOH-CP and acrolein. Assuming that thiol ionization is rapid enough so the equilibrium in eq. 1 is maintained, the concentration of thiolate is proportional to thiol concentration. Concentration of available nucleophile is determined by the thiol's pK a , which is ϳ8.7 for GSH, ϳ9.1 for mesna and ϳ7.7 for WR-1065 (Danehy and Noel, 1960; Whitesides et al., 1977; Shaked et al., 1980; Szajewski and Whitesides, 1980; Newton et al., 1992) . Calculating using the equation, pH ϭ pK a ϩ log (RS Ϫ /RSH), we find that, at pH 7.5, thiolate anion represents ϳ6% total GSH, ϳ2% total mesna, and ϳ39% total WR-1065. Thus, at pH 7.5, the effective rate constant for WR-1065 is expected to be ϳ6.5 times greater than that for GSH and ϳ20 times greater than that for mesna. The results in (Table 1) , whereas, from the percentage of thiolates calculated above, the ratio should be 6:2. This implies that factors other than pK a also determine relative rate constants.
Although the chemical reactions of thiols with alkylating agents are reversible, the rates of the reverse reactions are so slow that they have no effect on the measurements (see Results). This observation (that is, a slow reverse rate) is in agreement with the literature (Esterbauer et al., 1975; Wlodek, 1988; Ramu et al., 1995 Ramu et al., , 1996 .
The alkylating agents are known to produce cellular GSH depletion in vitro as well as in vivo (Gurtoo et al., 1981; Crook et al., 1986; Souid et al., 2001) . In the present study, the rates of cellular GSH depletion by acrolein and 4OOH-CP were measured, and the effective rate constants were determined (Fig. 4 -5 Table 1 ). This suggests that (a) the rate constants for intracellular reaction with GSH are the same as for extracellular reaction and (b) the rate of transport across the cell membrane is fast for both agents.
The concentration of acrolein that depletes cellular GSH by 50% is ϳ5-fold less than that of 4OOH-CP (ϳ7 M versus ϳ35 M; Fig. 4 , right and left panels, respectively). These results are in accord with the previous report in Chinese hamster lung fibroblast cells, showing a total cellular GSH depletion within 30 min incubation at 37°C with either 10 M acrolein or 100 M 4OOH-CP (Bunting and Townsend, 1998) .
Assuming the rate constants for reactions of thiols with alkylating agents were the same inside as outside cells, we were able to estimate the rate constants (k 1 ) for the transport across the cell membrane from the data of Figs. 4 That GSH reacts faster with acrolein than with 4OOH-CP (Table 1  and Fig. 5 ) is due partly to faster transport of acrolein across the cell membrane and partly to larger k 2 . The rapidity of the reaction explains the failure to obtain a complete cellular GSH protection even with 25-fold molar excess (i.e., 500 M) of WR-1065 or mesna (Fig. 6 , right panel), whereas a complete cellular GSH protection over 4OOH-CP is obtained with only a 10-fold molar excess of WR-1065 (i.e., 1 mM) (Fig. 6, left panel, circles) . Mesna (Fig. 6, left panel, squares) has a more limited cytoprotective capacity, since, in the presence of a 10-fold molar excess of mesna (i.e., 1 mM), cellular GSH was below 50%.
The results in Fig. 6 (left panel) are in accord with the previous 
Treatment of PBMC with various agents
PBMC (ϳ10 7 cells per condition) were incubated with indicated concentrations of mesna, WR-1065, or in combination at 37°C for 5 min. Acrolein was added to a final concentration of 20 M, and the incubation continued at 37°C for 60 min. The cells were then collected by centrifugation, suspended in 20 mM Tris-MSA, pH 8.0, containing 5 mM mBBr, and incubated at RT for 15 min. The amount of GSH in the cellular acid-soluble supernatants was determined on HPLC. The GSH content in the control sample (cells incubated with no additions) was set as 100%. dmd.aspetjournals.org study showing that mesna, GSH, and N-acetylcysteine protect Chinese hamster lung fibroblast cells from the toxic effects of 4-OOH-CP (Bunting and Townsend, 1998) . In another report, a 100-fold molar excess of mesna ameliorated Ͻ50% of the growth inhibitory activity of either 100 M 4OOH-CP or 100 M acrolein in various cell types (Blomgren and Hallstrom, 1991) . Moreover, binding of cyclophosphamide metabolites to intact cells or cellular components was decreased by only ϳ50% in the presence of an equal molar concentration of mesna or GSH (Wildenauer and Oehlmann, 1982) . The fact that a complete cytoprotection requires significant molar excess of WR-1065 over the alkylating agent (Fig. 6, left panel, circles) may account for the lack of cytoprotection by WR-2721 during very intensive chemotherapy (Shapiro et al., 1998) . Studies of cellular uptake of mesna and WR-1065 demonstrate that significant uptake of mesna does occur but at a level much less than that of WR-1065 (Souid et al., 2001) . For both agents, the predominant intracellular form is the free thiol (Souid et al., 2001 ). The present study shows that cytoprotection by WR-1065 and mesna is additive (Table 2) , supporting their clinical use in combination (Souid et al., 1999 (Souid et al., , 2001 .
Agents Added to Extracellular
The cytoprotective capacity of a thiol drug is influenced by its pK a , its rate of reaction with the alkylating agent, and the rate of its uptake by the cell. The data show a superior protection of cellular GSH by WR-1065. This observation is interpreted in terms of the rate constants derived from kinetic analysis of the measured depletion data. A kinetic model to interpret the protection data is also possible but would require assumed values for several parameters in addition to the measured rate constants.
